MW5076A1 - Pharmacologicalle active compounds - Google Patents

Pharmacologicalle active compounds

Info

Publication number
MW5076A1
MW5076A1 MW50/76A MW5076A MW5076A1 MW 5076 A1 MW5076 A1 MW 5076A1 MW 50/76 A MW50/76 A MW 50/76A MW 5076 A MW5076 A MW 5076A MW 5076 A1 MW5076 A1 MW 5076A1
Authority
MW
MALAWI
Prior art keywords
pharmacologicalle
active compounds
compounds
active
pharmacologicalle active
Prior art date
Application number
MW50/76A
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of MW5076A1 publication Critical patent/MW5076A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
MW50/76A 1975-12-29 1976-11-22 Pharmacologicalle active compounds MW5076A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5300175 1975-12-29

Publications (1)

Publication Number Publication Date
MW5076A1 true MW5076A1 (en) 1978-02-08

Family

ID=10466233

Family Applications (1)

Application Number Title Priority Date Filing Date
MW50/76A MW5076A1 (en) 1975-12-29 1976-11-22 Pharmacologicalle active compounds

Country Status (37)

Country Link
JP (1) JPS5283388A (en)
AR (1) AR222290A1 (en)
AT (1) AT360024B (en)
AU (1) AU508123B2 (en)
BE (1) BE849810A (en)
BG (1) BG29722A3 (en)
CA (1) CA1073458A (en)
CH (1) CH631981A5 (en)
CS (1) CS203995B2 (en)
DD (1) DD128588A5 (en)
DE (1) DE2658267A1 (en)
DK (1) DK587076A (en)
EG (1) EG12439A (en)
ES (1) ES454656A1 (en)
FI (1) FI62668C (en)
FR (1) FR2336935A1 (en)
GR (1) GR62441B (en)
HU (1) HU175171B (en)
IE (1) IE45082B1 (en)
IL (1) IL51040A (en)
IT (2) IT1124740B (en)
LU (1) LU76481A1 (en)
MW (1) MW5076A1 (en)
MX (1) MX5119E (en)
NL (1) NL7614538A (en)
NO (1) NO146396C (en)
NZ (1) NZ182759A (en)
OA (1) OA05526A (en)
PH (1) PH14723A (en)
PL (1) PL104376B1 (en)
PT (1) PT65949B (en)
RO (1) RO72475A (en)
SE (1) SE431544B (en)
SU (1) SU791235A3 (en)
YU (1) YU311676A (en)
ZA (1) ZA767198B (en)
ZM (1) ZM14376A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
IL56265A (en) * 1977-12-28 1982-08-31 Om Lab Sa Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor
IN151188B (en) * 1978-02-13 1983-03-05 Smith Kline French Lab
US4539207A (en) * 1978-02-13 1985-09-03 Smith Kline & French Laboratories Limited Pyrimidine compounds
IL57005A (en) * 1978-04-11 1983-11-30 Smith Kline French Lab Process for the preparation of 2-amino pyrimid-4-one derivatives and novel 2-nitroaminopyrimid-4-ones as intermediates therefor
ZA792607B (en) * 1978-05-30 1980-07-30 Smith Kline French Lab Nitro compounds
ZA793392B (en) * 1978-07-15 1980-08-27 Smith Kline French Lab Isoureas and isothioureas
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
US4374836A (en) 1978-10-16 1983-02-22 Imperial Chemical Industries Ltd. Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
US4255428A (en) 1979-03-24 1981-03-10 Smith Kline & French Laboratories Limited 5-(Hydroxypyridylalkyl)-4-pyrimidones
JPS55133379A (en) * 1979-04-05 1980-10-17 Smith Kline French Lab Pyrimidone compound
EP0017680B1 (en) * 1979-04-11 1982-04-21 Smith Kline & French Laboratories Limited Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them
JPS55145683A (en) * 1979-04-26 1980-11-13 Smith Kline French Lab Pyrimidone derivative
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
IN146736B (en) * 1975-10-02 1979-08-25 Smith Kline French Lab

Also Published As

Publication number Publication date
YU311676A (en) 1983-01-21
GR62441B (en) 1979-04-12
IT1124740B (en) 1986-05-14
SE7614620L (en) 1977-06-30
SU791235A3 (en) 1980-12-23
PL104376B1 (en) 1979-08-31
OA05526A (en) 1981-04-30
CA1073458A (en) 1980-03-11
NO764370L (en) 1977-06-30
CS203995B2 (en) 1981-03-31
IE45082L (en) 1977-06-29
FI62668C (en) 1983-02-10
HU175171B (en) 1980-05-28
JPS5283388A (en) 1977-07-12
DK587076A (en) 1977-06-30
AU508123B2 (en) 1980-03-13
AU2097676A (en) 1978-07-06
FI62668B (en) 1982-10-29
RO72475A (en) 1982-10-26
JPS6129355B2 (en) 1986-07-05
ES454656A1 (en) 1977-11-16
DE2658267A1 (en) 1977-07-07
SE431544B (en) 1984-02-13
FR2336935B1 (en) 1980-03-21
NZ182759A (en) 1978-06-02
IL51040A0 (en) 1977-02-28
PT65949B (en) 1978-06-15
AR222290A1 (en) 1981-05-15
FI763664A (en) 1977-06-30
ZA767198B (en) 1977-11-30
EG12439A (en) 1979-09-30
NO146396C (en) 1982-09-22
AT360024B (en) 1980-12-10
ZM14376A1 (en) 1977-08-22
NL7614538A (en) 1977-07-01
BG29722A3 (en) 1981-01-15
IT7919107A0 (en) 1979-01-05
IL51040A (en) 1980-12-31
DD128588A5 (en) 1977-11-30
BE849810A (en) 1977-06-23
IE45082B1 (en) 1982-06-16
PT65949A (en) 1977-01-01
LU76481A1 (en) 1977-06-15
MX5119E (en) 1983-03-24
FR2336935A1 (en) 1977-07-29
ATA960876A (en) 1980-05-15
NO146396B (en) 1982-06-14
PH14723A (en) 1981-11-13
CH631981A5 (en) 1982-09-15

Similar Documents

Publication Publication Date Title
JPS51131843A (en) Lipidddepleted active compound
GB1539006A (en) Aminoalkylammonium compound
ZA763652B (en) Pharmacologically active compounds
JPS57112388A (en) 1-sulfonylbenzimidazole compound
MW5076A1 (en) Pharmacologicalle active compounds
PT65590A (en) Pharmacologically active compounds
JPS51113900A (en) Riphamycin compound
ZM9876A1 (en) Pharmacologically active compounds
ZA765331B (en) Novel pharmaceutically active compounds
ZA7682B (en) Pharmacologically active compounds
ZA764267B (en) Sulphine compounds
GB1544103A (en) 3-acyloxymethyl-cephem compounds
JPS5223076A (en) Antiiinflammatory compound
ZM9676A1 (en) Pharmacologically active compounds
JPS51143699A (en) Riphamycin compound
ZA761324B (en) Pharmaceutically active compounds
JPS51115450A (en) Phosphorrcontaining compounds
JPS5236665A (en) 44dithioo33imide azethizinee 22one compound
ZA763837B (en) Pharmacologically active compounds
JPS5231095A (en) Cephlosporin type compound
JPS5231062A (en) Perfluoroalkylthionorbornane compound
ZM576A1 (en) Compounds
JPS5285106A (en) Carbamateesulphenyllcarbamoylfluoride compounds
ZA762536B (en) Pharmacologically active compounds
PT65839B (en) Pharmacologically active compounds